{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "12205903", "DateCompleted": {"Year": "2002", "Month": "12", "Day": "12"}, "DateRevised": {"Year": "2015", "Month": "11", "Day": "19"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"ISSN": "1001-5302", "JournalIssue": {"Volume": "24", "Issue": "9", "PubDate": {"Year": "1999", "Month": "Sep"}}, "Title": "Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica", "ISOAbbreviation": "Zhongguo Zhong Yao Za Zhi"}, "ArticleTitle": "[Synergistic interaction between Ys-96, a bisbenzylisoquinoline compound derived from Stephania tetrandra, and adriamycin or vincristine against human cancer cell lines in vitro].", "Pagination": {"StartPage": "556", "EndPage": "576", "MedlinePgn": "556-9, 576"}, "Abstract": {"AbstractText": ["To study in vitro the anticancer interaction between Ys-96, a bisbenzylisoquinoline compound derived from Stephania tetrandra, and adriamycin or vincristine against human cancer cell lines.", "Using human breast cancer cell MCF-7 and its adriamycin-resistant cell line MCF-7/Adr, and human nasopharyngeal cancer cell KB and its vincristine-resistant cell line KBv200 in an in vitro system, anticancer interaction between Ys-96 and adriamycin or vincristine was evaluated with a method reported by Berenbaum.", "The SFIC values (sum of fractional inhibitory concentration) of the combinations with 3 different ratios between Ys-96 and adriamycin or vincristine were markedly less than 1.0, and the shapes of all the isobologram curves were concave.", "The synergistic interaction between Ys-96 and adriamycin or vincristine against the above human cancer cell lines was positively observed in vitro."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Materia Medica, China Academy of Traditional Chinese Medicine, Beijing 100700."}], "Identifier": [], "LastName": "Ye", "ForeName": "Z", "Initials": "Z"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sun", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "C", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Xue", "ForeName": "B", "Initials": "B"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liang", "ForeName": "A", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Z", "Initials": "Z"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tong", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Feng", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["English Abstract", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhongguo Zhong Yao Za Zhi", "NlmUniqueID": "8913656", "ISSNLinking": "1001-5302"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Isoquinolines"}, {"RegistryNumber": "5J49Q6B70F", "NameOfSubstance": "Vincristine"}, {"RegistryNumber": "80168379AG", "NameOfSubstance": "Doxorubicin"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Combined Chemotherapy Protocols"}, {"QualifierName": [], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": ["pathology"], "DescriptorName": "Breast Neoplasms"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Doxorubicin"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Neoplasm"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Isoquinolines"}, {"QualifierName": ["pathology"], "DescriptorName": "Mouth Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Stephania tetrandra"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Cells, Cultured"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Vincristine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2002", "Month": "9", "Day": "11", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "12", "Day": "13", "Hour": "4", "Minute": "0"}, {"Year": "2002", "Month": "9", "Day": "11", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["12205903"]}}], "PubmedBookArticle": []}